Patients’ perspectives on the COPD-GRIP intervention, a new nursing care intervention for COPD

Por Zwakman, Marieke, Weldam, Saskia W. M., Vervoort, Sigrid C. J. M., Lammers, Jan-Willem J., Schuurmans, Marieke J.
Publicado no BMC Fam Pract (2019)

Patients’ perspectives on the COPD-GRIP intervention, a new nursing care intervention for COPD

Por Marieke Zwakman, Saskia W. M. Weldam, Sigrid C. J. M. Vervoort, Jan-Willem J. Lammers, Marieke J. Schuurmans
Publicado em 2019-06-01

Biomass smoke COPD has less tomographic abnormalities but worse hypoxemia compared with tobacco COPD

Por Meneghini, A.C., Koenigkam-Santos, M., Pereira, M.C., Tonidandel, P.R., Terra-Filho, J., Cunha, F.Q., de Menezes, M.B., Vianna, E.O.
Publicado no Braz J Med Biol Res (2019)

Reliability, validity and responsiveness of E-RS:COPD in patients with spirometric asthma-COPD overlap

Por Nelsen, Linda M., Lee, Laurie A., Wu, Wei, Lin, Xiwu, Murray, Lindsey, Pascoe, Steven J., Leidy, Nancy K.
Publicado no Respir Res (2019)

The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease

Por Revill, S, Morgan, M, Singh, S, Williams, J, Hardman, A
Publicado em 1999

Identifying the heterogeneity of COPD by V/P SPECT: a new tool for improving the diagnosis...

Por Bajc, M, Chen, Y, Wang, J, Li, XY, Shen, WM, Wang, CZ, Huang, H, Lindqvist, A, He, XY
Publicado no Int J Chron Obstruct Pulmon Dis (2017)

Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD

Por Tonnel, A-B, Perez, T, Grosbois, J-M, Verkindre, C, Bravo, M-L, Brun, M
Publicado em 2008

Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD

Por A-B Tonnel, T Perez, J-M Grosbois, C Verkindre, M-L Bravo, et al
Publicado em 2008-06-01

Aberrant DNA methylation and expression of SPDEF and FOXA2 in airway epithelium of patients with COPD

Por Song, J., Heijink, I. H., Kistemaker, L. E. M., Reinders-Luinge, M., Kooistra, W., Noordhoek, J. A., Gosens, R., Brandsma, C. A., Timens, W., Hiemstra, P. S., Rots, M. G., Hylkema, M. N.
Publicado no Clin Epigenetics (2017)

MFG-E8, a clearance glycoprotein of apoptotic cells, as a new marker of disease severity in chronic obstructive pulmonary disease

Por S. Zhang, J.G. Xie, B.T. Su, J.L. Li, N. Hu, J. Chen, G.W. Luo, T.P. Cui
Publicado em 2015-11-01

Lung-specific inactivation of CCAAT/enhancer binding protein α causes a pathological pattern characteristic of COPD

Por Didon, L., Roos, A.B., Elmberger, G.P., Gonzalez, F.J., Nord, M.
Publicado no Eur Respir J (2009)

Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments

Por Trudo, Frank, Kern, David M, Davis, Jill R, Tunceli, Ozgur, Zhou, Siting, Graham, Emma L, Strange, Charlie, Williams, Setareh A
Publicado no Int J Chron Obstruct Pulmon Dis (2015)

Efficacy and safety profile of xanthines in COPD: a network meta-analysis

Por Mario Cazzola, Luigino Calzetta, Peter J. Barnes, Gerard J. Criner, Fernando J. Martinez, Alberto Papi, Maria Gabriella Matera
Publicado em 2018-05-01

Roflumilast, a phosphodiesterase-4 inhibitor, induces phagocytic activity in Greek COPD patients

Por Porpodis K, Domvri K, Zarogoulidis P, Petridis D, Tsirgogianni K, Papaioannou A, Hatzizisi O, Kioumis I, Liaka A, Kikidaki V, Lampaki S, Organtzis J, Zarogoulidis K
Publicado em 2015-06-01

Impact of Oscillating Positive Expiratory Pressure Device Use on Post-Discharge Hospitalizations: A Retrospective Cohort Study Comparing Patients with COPD or Chronic Bronchitis Using the Aerobika&reg...

Por Tse J, Wada K, Wang Y, Coppolo D, Kushnarev V, Suggett J
Publicado em 2020-10-01

Differential Activation of Killer Cells in the Circulation and the Lung: A Study of Current Smoking Status and Chronic Obstructive Pulmonary Disease (COPD)

Por Wang, Jia, Urbanowicz, Richard A., Tighe, Patrick J., Todd, Ian, Corne, Jonathan M., Fairclough, Lucy C.
Publicado em 2013

Safety and tolerability of inhalational anticholinergics in COPD

Por Sharafkhaneh, Amir, Majid, Hashir, Gross, Nicholas J
Publicado em 2013

Nasal highflow improves ventilation in patients with COPD

Por Bräunlich J, Köhler M, Wirtz H
Publicado em 2016-05-01

Safety and tolerability of inhalational anticholinergics in COPD

Por Sharafkhaneh A, Majid H, Gross NJ
Publicado em 2013-03-01

Clinical, physiologic, and radiographic factors contributing to development of hypoxemia in moderate to severe COPD: a cohort study

Por Wells, J. Michael, Estepar, Raul San Jose, McDonald, Merry-Lynn N., Bhatt, Surya P., Diaz, Alejandro A., Bailey, William C., Jacobson, Francine L., Dransfield, Mark T., Washko, George R., Make, Barry J., Casaburi, Richard, van Beek, Edwin J. R., Hoffman, Eric A., Sciurba, Frank C., Crapo, James D., Silverman, Edwin K., Hersh, Craig P.
Publicado no BMC Pulm Med (2016)